|
|
|
|
| LEADER |
03432nmm a2200289 u 4500 |
| 001 |
EB000621919 |
| 003 |
EBX01000000000000000475001 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9781461322870
|
| 100 |
1 |
|
|a Friedman, E.A.
|e [editor]
|
| 245 |
0 |
0 |
|a Diabetic Nephropathy
|h Elektronische Ressource
|b Strategy for Therapy
|c edited by E.A. Friedman, Charles M. Peterson
|
| 250 |
|
|
|a 1st ed. 1986
|
| 260 |
|
|
|a New York, NY
|b Springer US
|c 1986, 1986
|
| 300 |
|
|
|a XVII, 254 p. 71 illus
|b online resource
|
| 505 |
0 |
|
|a 1. What is diabetes? Types, definitions, epidemiology, diagnosis -- 2. Insulin, oral agents, and monitoring techniques -- 3. Insulin pumps: for whom, when, why? -- 4. Clinical evaluation and management of diabetic retinopathy -- 5. Natural history of diabetic nephropathy -- 6. Hemodialysis for the uremic diabetic -- 7. Continuous ambulatory peritoneal dialysis in end-stage diabetic nephropathy -- 8. Options in uremia therapy: kidney transplantation -- 9. Pancreas transplants in diabetic nephropathy -- 10. Preservation of the compromised foot in diabetic nephropathy -- 11. Managing the diabetic renal-retinal syndrome during pregnancy -- 12. Nurse to nurse: nursing role in diabetic nephropathy management -- 13. Patient to patient -- 14. Is diabetic nephropathy preventable? -- Epilogue by Eli A. Friedman -- Appendix A: Your diabetic renal diet by Mildred Friedman -- Appendix B: Ideal weight tables -- Appendix C: Patient resources for addtional help
|
| 653 |
|
|
|a Diseases
|
| 653 |
|
|
|a Nephrology
|
| 700 |
1 |
|
|a Peterson, Charles M.
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 490 |
0 |
|
|a Developments in Nephrology
|
| 028 |
5 |
0 |
|a 10.1007/978-1-4613-2287-0
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4613-2287-0?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.61
|
| 520 |
|
|
|a Diabetic nephropathy is a tragic illness. Its often insidious onset in the insulin dependent (type I) diabetic, typically a young adult, heralds the last act in the course of a disease that will increasingly become the dominant preoccupation in the patient's shortened life. For most type II diabetics, the beginning of clinical renal insufficiency is but a phase in a continuous deterioration that affects the integrity ofjob, marriage, and family. The nephropathic diabetic is hypertensive, has worsening retinopathy, and more often than not, is also plagued by peripheral vascular insufficiency, heart disease, gastrointestinal malfunction, and deepening depression. Until the 1980's, few type I diabetics who became uremic (because ofdiabetic nephropathy) lived for more than two years. Hardly any attained true rehabilitation. This dismal prognosis is changing substantially for the better. Research in diabetes has resulted in striking advances at both ends of the type I diabetic's natural history. In one exciting clinical trial now underway in London, Ontario, halfofchildhood diabetics treated with cyclosporine within six weeks of onset evince"permanent" disappearanceofhyperglycemia and the need for insulin. At the otherendofthe natural historyofdiabetes for the nephropathic patientwith worsening eye disease (renal-retinal syndrome), who receives a kidney transplant, patient and graft survival, two years after cadaveric kidney transplantation in type I diabetics is now equal to that of the nondiabetic
|